Neuberger Berman Group
INSM icon

Neuberger Berman Group’s Insmed INSM Stock Holding History

Neuberger Berman Group’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$44.3M Buy
270,700
+62,831
+30% +$9.66M 0.03% 503
2025
Q4 		$36.2M Buy
207,869
+57,763
+38% +$10.5M 0.03% 533
2025
Q3 		$21.6M Buy
150,106
+139,211
+1,278% +$17.1M 0.02% 653
2025
Q2 		$1.1M Sell
10,895
-165,738
-94% -$12.7M ﹤0.01% 1325
2025
Q1 		$13.5M Buy
176,633
+27,392
+18% +$2.1M 0.01% 709
2024
Q4 		$10.3M Buy
149,241
+37,403
+33% +$2.69M 0.01% 802
2024
Q3 		$8.16M Sell
111,838
-1,910
-2% -$141K 0.01% 835
2024
Q2 		$7.62M Sell
113,748
-57,169
-33% -$2.22M 0.01% 819
2024
Q1 		$4.64M Buy
170,917
+1,989
+1% +$55.7K ﹤0.01% 946
2023
Q4 		$5.24M Buy
168,928
+59,424
+54% +$1.54M ﹤0.01% 901
2023
Q3 		$2.76M Sell
109,504
-146,706
-57% -$3.36M ﹤0.01% 1017
2023
Q2 		$5.41M Buy
256,210
+107,402
+72% +$2.04M ﹤0.01% 871
2023
Q1 		$2.54M Buy
148,808
+11,245
+8% +$218K ﹤0.01% 1030
2022
Q4 		$2.75M Buy
137,563
+50,204
+57% +$970K ﹤0.01% 998
2022
Q3 		$1.88M Sell
87,359
-288
-0.3% -$6.91K ﹤0.01% 1097
2022
Q2 		$1.73M Buy
87,647
+36,347
+71% +$762K ﹤0.01% 1149
2022
Q1 		$1.21M Buy
51,300
+5,113
+11% +$119K ﹤0.01% 1300
2021
Q4 		$1.25M Buy
46,187
+30
+0.1% +$858 ﹤0.01% 1297
2021
Q3 		$1.26M Sell
46,157
-75,000
-62% -$1.97M ﹤0.01% 1261
2021
Q2 		$3.44M Buy
+121,157
New +$3.6M ﹤0.01% 1053
2015
Q3 		– Sell
-34,400
Closed -$840K – 1559
2015
Q2 		$840K Buy
34,400
+8,400
+32% +$191K ﹤0.01% 1237
2015
Q1 		$541K Buy
+26,000
New +$458K ﹤0.01% 1330
2013
Q4 		– Sell
-86,900
Closed -$1.36M – 1638
2013
Q3 		$1.36M Buy
+86,900
New +$1.1M ﹤0.01% 1140

Other funds holding INSM

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Neuberger Berman Group's INSM Position: Q1 2026 in Review

Neuberger Berman Group increased its Insmed (INSM) stake by 30% in Q1 2026, buying an estimated $9.66M and bringing the position to 270,700 shares worth $44.3M. The position accounts for 0.03% of the portfolio, ranked #503.

Neuberger Berman Group first reported a position in INSM in Q3 2013 and has held it in 23 quarters since. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Neuberger Berman Group held 270,700 shares of Insmed worth $44.3M as of Q1 2026.
  • Neuberger Berman Group bought 62,831 Insmed shares in Q1 2026, an estimated $9.66M.
  • Insmed made up 0.03% of Neuberger Berman Group's portfolio in Q1 2026, its #503 holding.
  • Neuberger Berman Group first reported a position in Insmed in Q3 2013 and has held it in 23 quarters since.
  • 669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Neuberger Berman Group's 13F filing for Q1 2026, filed 14 May 2026.